This is a preview of subscription content, log in via an institution to check access.
Notes
Functional Assessment of Chronic Illness Therapy
Reference
Strand V, et al. Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials. Annals of the Rheumatic Diseases : 22 Mar 2013. Available from: URL: http://dx.doi.org/10.1136/annrheumdis-2012-202865
Rights and permissions
About this article
Cite this article
Belimumab improves QOL in SLE. PharmacoEcon Outcomes News 676, 10 (2013). https://doi.org/10.1007/s40274-013-0335-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0335-4